miR-30c and miR-193 are a part of the TGF-β-dependent regulatory network controlling extracellular matrix genes in liver fibrosis

Journal of Digestive Diseases

Volumn 16, Issue 9, 2015, Pages 513-524

  Roy, Sanchari ^a   Benz, Fabian ^a   Vargas Cardenas, David ^a   Vucur, Mihael ^a   Gautheron, Jeremie ^a   Schneider, Anne ^a   Hellerbrand, Claus ^b   Pottier, Nicolas ^c   Alder, Jan ^a   Tacke, Frank ^a   Trautwein, Christian ^a   Roderburg, Christoph ^a   Luedde, Tom ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UFR3S Pharmacie   (France)

Author keywords

Hepatic stellate cells; Liver fibrosis; microRANs; MiR 193; MiR 30; Transforming growth factor beta

Indexed keywords

CARBON TETRACHLORIDE; MICRORNA; MICRORNA 133; MICRORNA 193; MICRORNA 29; MICRORNA 30C; RNA DERIVATIVE; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN193 MICRORNA, HUMAN; MIRN193 MICRORNA, MOUSE; MIRN30 MICRORNA, HUMAN; MIRN30D MICRORNA, MOUSE; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; FIBROGENESIS; GENE CONTROL; GENE EXPRESSION; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOUSE; MURINE MODEL; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; STELLATE CELL; ANIMAL; AREA UNDER THE CURVE; BLOOD; CELL CULTURE; CHEMICALLY INDUCED; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; LIVER CIRRHOSIS; METABOLISM; RECEIVER OPERATING CHARACTERISTIC;

ANIMALS; AREA UNDER CURVE; BIOMARKERS; CARBON TETRACHLORIDE; CELLS, CULTURED; DOWN-REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; MICE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ROC CURVE; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84942521305     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12266     Document Type: Article

References (37)

1. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 2012; 18: 1028-1040.
2. Tacke F, Weiskirchen R. Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques. Expert Rev Gastroenterol Hepatol 2012; 6: 67-80.
3. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-218.
4. Meyer C, Godoy P, Bachmann A etal. Distinct role of endocytosis for Smad and non-Smad TGF-beta signaling regulation in hepatocytes. J Hepatol 2011; 55: 369-378.
5. Yin OQ, Gallagher N, Tanaka C etal. Effects of hepatic impairment on the pharmacokinetics of nilotinib: an open-label, single-dose, parallel-group study. Clin Ther 2009; 31 (Pt 2): 2459-2469.
6. Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009; 136: 586-591.
7. Davis BN, Hata A. Regulation of MicroRNA biogenesis: a miRiad of mechanisms. Cell Commun Signal 2009; 7: 18.
8. Roderburg C, Urban GW, Bettermann K etal. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011; 53: 209-218.
9. Roderburg C, Luedde M, Vargas Cardenas D etal. miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J Hepatol 2013; 58: 736-742.
10. Bandiera S, Pfeffer S, Baumert TF, Zeisel MB. miR-122 - a key factor and therapeutic target in liver disease. J Hepatol 2015; 62: 448-457.
11. Guo CJ, Pan Q, Li DG, Sun H, Liu BW. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J Hepatol 2009; 50: 766-778.
12. Yang JJ, Tao H, Hu W etal. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis. Cell Signal 2014; 26: 2381-2389.
13. Tu X, Zhang H, Zhang J etal. MicroRNA-101 suppresses liver fibrosis by targeting the TGFbeta signalling pathway. J Pathol 2014; 234: 46-59.
14. Margis R, Borojevic R. Retinoid-mediated induction of the fat-storing phenotype in a liver connective tissue cell line (GRX). Biochim Biophys Acta 1989; 1011: 1-5.
15. Borojevic R, Monteiro AN, Vinhas SA etal. Establishment of a continuous cell line from fibrotic schistosomal granulomas in mice livers. In Vitro Cell Dev Biol 1985; 21: 382-390.
16. Affò S, Morales-Ibanez O, Rodrigo-Torres D etal. CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis. Gut 2014; 63: 1782-1792.
17. Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. J Hepatol 2012; 56: 1171-1180.
18. Jiang F, Liu GS, Dusting GJ, Chan EC. NADPH oxidase-dependent redox signaling in TGF-beta-mediated fibrotic responses. Redox Biol 2014; 2: 267-272.
19. Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol 2014; 14: 181-194.
20. Zhang J, Zhang H, Liu J etal. miR-30 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Biochem Biophys Res Commun 2012; 417: 1100-1105.
21. Liu J, Eischeid AN, Chen XM. Col1A1 production and apoptotic resistance in TGF-beta1-induced epithelial-to-mesenchymal transition-like phenotype of 603B cells. PLoS ONE 2012; 7: e51371.
22. Shimada H, Staten NR, Rajagopalan LE. TGF-beta1 mediated activation of Rho kinase induces TGF-beta2 and endothelin-1 expression in human hepatic stellate cells. J Hepatol 2011; 54: 521-528.
23. Atorrasagasti C, Aquino JB, Hofman L etal. SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-beta1 and PDGF. Am J Physiol Gastrointest Liver Physiol 2011; 300: G739-748.
24. Roderburg C, Mollnow T, Bongaerts B etal. Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis. PLoS ONE 2012; 7: e32999.
25. Lino Cardenas CL, Henaoui IS, Courcot E etal. miR-199a-5p is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1. PLoS Genet 2013; 9: e1003291.
26. Inagaki Y, Okazaki I. Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 2007; 56: 284-292.
27. He Y, Huang C, Sun X, Long XR, Lv XW, Li J. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal 2012; 24: 1923-1930.
28. Tsukada S, Westwick JK, Ikejima K, Sato N, Rippe RA. SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cells. J Biol Chem 2005; 280: 10055-10064.
29. Szuster-Ciesielska A, Mizerska-Dudka M, Daniluk J, Kandefer-Szerszeń M. Butein inhibits ethanol-induced activation of liver stellate cells through TGF-beta, NFkappaB, p38, and JNK signaling pathways and inhibition of oxidative stress. J Gastroenterol 2013; 48: 222-237.
30. Roderburg C, Luedde T. Circulating microRNAs as markers of liver inflammation, fibrosis and cancer. J Hepatol 2014; 61: 1434-1437.
31. Roderburg C, Benz F, Vargas Cardenas D etal. Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. Liver Int 2015; 35: 1172-1184.
32. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-659.
33. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids - the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011; 8: 467-477.
34. Shan H, Zhang Y, Lu Y etal. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 2009; 83: 465-472.
35. Nakasa T, Ishikawa M, Shi M, Shibuya H, Adachi N, Ochi M. Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model. J Cell Mol Med 2010; 14: 2495-2505.
36. Matkovich SJ, Wang W, Tu Y etal. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res 2010; 106: 166-175.
37. Cacchiarelli D, Legnini I, Martone J etal. miRNA as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med 2011; 3: 258-265.